Susquehanna International Group
AUGX

Susquehanna International Group’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Susquehanna International Group’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-130,434
Closed -$307K – 13620
2024
Q3 		$307K Buy
130,434
+105,558
+424% +$213K ﹤0.01% 9554
2024
Q2 		$21.9K Sell
24,876
-238,311
-91% -$491K ﹤0.01% 11646
2024
Q1 		$1.08M Buy
263,187
+101,322
+63% +$453K ﹤0.01% 6714
2023
Q4 		$947K Buy
161,865
+47,542
+42% +$250K ﹤0.01% 7115
2023
Q3 		$589K Buy
114,323
+68,250
+148% +$320K ﹤0.01% 7851
2023
Q2 		$222K Buy
+46,073
New +$159K ﹤0.01% 10068

Susquehanna International Group's AUGX Position: Q4 2024 in Review

Susquehanna International Group sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 130,434 shares — an estimated $307K sold.

Susquehanna International Group first reported a position in AUGX in Q2 2023 and held it in 6 quarters. The position peaked at $1.08M in Q1 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Susquehanna International Group reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 130,434 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $307K.
  • Susquehanna International Group first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
  • Susquehanna International Group's Augmedix, Inc. Common Stock position peaked at $1.08M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.